Found 1061 clinical trials
l Investigation of Robotic-assisted TKA (RA-TKA) With Skywalker and Evolution Medial Pivot Knee (eMP Knee) (123)
This is a prospective trial that attempts to develop evidence on the safety and performance of RA-TKA (Robotic-assisted total knee arthroplasty) with Skywalker and eMP (Evolution Medial Pivot) knee. Moreover to evaluate performance of eMP patients with Skywalker (in comparison to eMP with conventional instrumentations and non-MP TKAs)
- 0 views
- 19 May, 2025
- Online study
Individualizing Treatment for Asthma in Primary Care (Full Study) (iTREAT-PC)
This study will compare two currently available approaches to reduce AEX in primary care patients: (1) use of inhaled corticosteroids (ICS) as part of rescue therapy, also known as MART (Maintenance And Reliever Therapy) or PARTICS (Patient Activated Reliever Trigger Inhaled Corticosteriods) therapy - either of these therapies will be …
- 0 views
- 24 Nov, 2025
Automated Inhaler Monitoring for Asthma Medication Usage (AIM)
The main questions the trial aims to answer are:Does the platform improve medication adherence and inhaler technique, as measured by the Inhaler Proficiency Score (IPS)?Does the aflo™ platform improve asthma control, as measured by changes in the Asthma Control Test (ACT) and lung function tests (FEV1, PEF)?
- 0 views
- 24 Nov, 2025
Diffusion MRI for Head and Neck Cancer
However, it is often underappreciated that these dMRI metrics are not fixed constants, but rather functions of the diffusion time t, D(t) and K(t); their t-dependency is determined by tissue properties, such as cell size and membrane permeability of tissue. D(t) and K(t) of tumors can vary substantially depending on …
- 0 views
- 29 Jul, 2025
The Potential Added Value of Impulse Oscillometry in Asthma Monitoring (AM-IOS)
Is there a difference in the change in IOS parameters and FEV1 respectively, stratified according to change in other questionnaire such as the asthma control questionnaire and the asthma quality of life questionnaire.Are the proposed minimal clinically important differences (MCIDs) valid for short follow-up periods (3 - 6 months)?
- 0 views
- 24 Nov, 2025
Expertise Asthma COPD Program with Digital Support (EXACT@home)
The aim EXACT@Home is to create an evidence-based health program using e.g. questionnaires, a digital health platform and multiple digital devices to further improve the assessment of patients diagnosed with severe asthma. By better charting treatable traits (e.g. poor adherence, physical inactivity, dysfunctional breathing), we expect to improve the indication …
- 0 views
- 24 Nov, 2025
Study to test asthama
To determine the etiology and clinical presentation of increased serum ammonia in infants and children presented to the Pediatric Genetic unit, Assiut University Hospital-To study the effects of certain precautions on serum ammonia levels.
- 0 views
- 07 Mar, 2025
- 1 location
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
A Phase I study to evaluate the safety of a novel, orally available, selective, and potent small molecule inhibitor of the histone lysine methyl transferase MMSET (also known as NSD2/WHSC1) to prevent the dimethylation of H3K36 in adult patients with relapsed or refractory multiple myeloma (RRMM).
- 0 views
- 24 Nov, 2025
Switch Maintenance in Pancreatic
The names of the study drugs involved in this study are:Domvanalimab (also known as AB154)Zimberelimab (also known as AB122)APX005M
- 0 views
- 24 Nov, 2025
Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas (CIRTUSARC)
The study is a Phase 2 clinical trial of the drug cirtuvivint as a second-line treatment for advanced soft tissue sarcomas. The study is being conducted in Spain and is expected to enroll approximately 25 patients in total.
- 0 views
- 24 Jun, 2025